Literature DB >> 455891

Kinetics of intravenous mezlocillin in chronic hemodialysis patients.

E Francke, S Mehta, H C Neu, G B Appel.   

Abstract

The kinetics of intravenous mezlocillin was studied in 8 patients with creatinine clearances under 7 ml/min who were undergoing chronic hemodialysis. Kinetic parameters were determined using a 2-compartment linear model. The mezlocillin serum half-life (t 1/2) in these patients ranged from 2.9 to 7.8 hr (mean, 5.4). The t 1/2 decreased to 1.57 +/- 0.09 hr during dialysis. Approximately 18% of the dose was recovered in the dialysate in 4 hr of dialysis. There was a 30% reduction per hour in serum concentration. The kinetics of mezlocillin, due to removal by nonrenal mechanisms, more closely resemble the kinetics of penicillin G and ampicillin than of carbenicillin and ticarcillin. A dosage schedule for use of intravenous mezlocillin in patients undergoing hemodialysis is presented.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455891     DOI: 10.1002/cpt1979262228

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

Review 1.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

2.  Mezlocillin pharmacokinetics in pediatric oncology patients.

Authors:  W G Kramer; L K Pickering; S Culbert; L S Frankel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

3.  Mezlocillin disposition in chronic hemodialysis patients.

Authors:  D M Janicke; A Mangione; R W Schultz; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.